Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer

Nature Metabolism · Published 2026-07-23 · DOI 10.1038/s42255-026-01578-w

Free full text

Authors (49)

Deborah Y. Moss, Connor N. Brown, Andrew M. Shaw, Christopher McCann, Nikita Lewis, Matilda Downs, Rebecca Wurelly, Ciara Cunningham, Aaron Philips, Niamh Doherty, Sarah Gallagher, William J. McDaid, Andrew Roe, Aisling Y. Coughlan, Brenton Cavanagh, Callum Ormsby, Fiammetta Falcone, Rachel McCole, Scott Monteith, Emily Rogan, Sudhir B. Malla, Alexandra J. Emerson, Letitia Mohammed-Smith, Shaun Sharkey, Aoife Leonard, Peter F. Gallagher, Arindam Banerjee, Sandra Van Schaeybroeck, Sufyan Pandor, Brian Quinn, Brett Greer, Christopher Elliott, Sarah Maguire, Aideen E. Ryan, Philip D. Dunne, Mary Mallon, Stephanie Craig, Omar Aftab, Laura C. Greaves, Bryan P. Marzullo, Daniel A. Tennant, Vicky Coyle, Ian G. Mills, Owen Sansom, Tríona Ní Chonghaile, Daniel B. Longley, Simon S. McDade, Melissa J. LaBonte, Emma M. Kerr

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Moss, D., Brown, C., Shaw, A., et al. (2026). Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer. Nature Metabolism. https://doi.org/10.1038/s42255-026-01578-w

Related articles